Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Generac Holdings
GNRC
$12.9B
| $1.57M | ﹤0.01% |
10,158
-56,766
| -85% | -$9.81M |
|
1552
UroGen Pharma
URGN
$1.88B
| $1.57M | ﹤0.01% |
146,953
+9,653
| +7% | +$116K |
|
1553
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
| $1.56M | ﹤0.01% |
16,071
+9,559
| +147% | +$911K |
|
1554
Farmers National Banc Corp
FMNB
$946M
| $1.55M | ﹤0.01% |
108,917
| – | – |
|
1555
Immunome
IMNM
$2.84B
| $1.55M | ﹤0.01% |
145,564
+4,874
| +3% | +$58.9K |
|
1556
Eastman Chemical
EMN
$8.23B
| $1.54M | ﹤0.01% |
+16,900
| New | +$1.73M |
|
1557
Monte Rosa Therapeutics
GLUE
$1.3B
| $1.54M | ﹤0.01% |
221,741
+4,740
| +2% | +$35.6K |
|
1558
Pampa Energía
PAM
$4.66B
| $1.51M | ﹤0.01% |
+17,198
| New | +$1.31M |
|
|
ACLX
1559
DELISTED
Arcellx
ACLX
| $1.51M | ﹤0.01% |
19,693
-1,275
| -6% | -$110K |
|
1560
Oric Pharmaceuticals
ORIC
$1.1B
| $1.5M | ﹤0.01% |
186,430
+12,042
| +7% | +$110K |
|
1561
Trump Media & Technology Group
DJT
$2.86B
| $1.5M | ﹤0.01% |
+43,919
| New | +$1.4M |
|
1562
Stoke Therapeutics
STOK
$1.84B
| $1.49M | ﹤0.01% |
134,812
-2,163
| -2% | -$26.6K |
|
1563
Voyager Therapeutics
VYGR
$181M
| $1.48M | ﹤0.01% |
261,251
+31,882
| +14% | +$206K |
|
1564
Altimmune
ALT
$583M
| $1.48M | ﹤0.01% |
205,233
+8,001
| +4% | +$61.1K |
|
1565
CorMedix
CRMD
$592M
| $1.45M | ﹤0.01% |
178,786
-2,162
| -1% | -$21.6K |
|
1566
InterDigital
IDCC
$7.98B
| $1.44M | ﹤0.01% |
7,439
-148,261
| -95% | -$25.9M |
|
1567
Rhythm Pharmaceuticals
RYTM
$7.26B
| $1.43M | ﹤0.01% |
25,555
-2,161
| -8% | -$119K |
|
1568
Ferrovial N.V. Ordinary Shares
FER
$47.6B
| $1.42M | ﹤0.01% |
34,100
+821
| +2% | +$33.4K |
|
1569
Affiliated Managers Group
AMG
$10.1B
| $1.42M | ﹤0.01% |
7,659
-6,137
| -44% | -$1.15M |
|
|
TRML
1570
DELISTED
Tourmaline Bio
TRML
| $1.39M | ﹤0.01% |
68,599
+2,858
| +4% | +$72K |
|
1571
Kiniksa Pharmaceuticals
KNSA
$5.73B
| $1.38M | ﹤0.01% |
69,813
+22,096
| +46% | +$504K |
|
1572
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $1.38M | ﹤0.01% |
12,302
-1,490
| -11% | -$159K |
|
1573
Annexon
ANNX
$860M
| $1.38M | ﹤0.01% |
268,166
+4,806
| +2% | +$29.6K |
|
|
DFTX
1574
Definium Therapeutics
DFTX
$5.55B
| $1.35M | ﹤0.01% |
194,491
+8,769
| +5% | +$60.3K |
|
1575
Aecom
ACM
$9.61B
| $1.35M | ﹤0.01% |
12,602
+603
| +5% | +$65.8K |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.